These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 27480852

  • 41. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
    Eschenauer GA, Nguyen MH, Shoham S, Vazquez JA, Morris AJ, Pasculle WA, Kubin CJ, Klinker KP, Carver PL, Hanson KE, Chen S, Lam SW, Potoski BA, Clarke LG, Shields RK, Clancy CJ.
    Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
    [Abstract] [Full Text] [Related]

  • 42. In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.
    Fernández-Silva F, Lackner M, Capilla J, Mayayo E, Sutton D, Castanheira M, Fothergill AW, Lass-Flörl C, Guarro J.
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3646-9. PubMed ID: 24733474
    [Abstract] [Full Text] [Related]

  • 43. Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.
    Healey KR, Katiyar SK, Castanheira M, Pfaller MA, Edlind TD.
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3947-9. PubMed ID: 21628537
    [Abstract] [Full Text] [Related]

  • 44. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
    Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS.
    Antimicrob Agents Chemother; 2010 Jan; 54(1):426-39. PubMed ID: 19884370
    [Abstract] [Full Text] [Related]

  • 45. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS.
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [Abstract] [Full Text] [Related]

  • 46. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA, Carvalhaes C, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015043
    [Abstract] [Full Text] [Related]

  • 47. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
    Kucharíková S, Tournu H, Lagrou K, Van Dijck P, Bujdáková H.
    J Med Microbiol; 2011 Sep 24; 60(Pt 9):1261-1269. PubMed ID: 21566087
    [Abstract] [Full Text] [Related]

  • 48. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA.
    Clin Infect Dis; 2013 Jun 24; 56(12):1724-32. PubMed ID: 23487382
    [Abstract] [Full Text] [Related]

  • 49. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
    Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.
    Antimicrob Agents Chemother; 2013 Jun 24; 57(6):2562-70. PubMed ID: 23529739
    [Abstract] [Full Text] [Related]

  • 50. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
    Deorukhkar SC, Saini S.
    Infect Disord Drug Targets; 2016 Jun 24; 16(1):63-8. PubMed ID: 26648186
    [Abstract] [Full Text] [Related]

  • 51. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
    Thierry G, Morio F, Le Pape P, Gay-Andrieu F, Barre O, Miegeville M.
    Pathol Biol (Paris); 2011 Feb 24; 59(1):52-6. PubMed ID: 20832195
    [Abstract] [Full Text] [Related]

  • 52. Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.
    Castanheira M, Woosley LN, Messer SA, Diekema DJ, Jones RN, Pfaller MA.
    Antimicrob Agents Chemother; 2014 Feb 24; 58(1):577-80. PubMed ID: 24126582
    [Abstract] [Full Text] [Related]

  • 53. Echinocandin Resistance in Candida.
    Perlin DS.
    Clin Infect Dis; 2015 Dec 01; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
    [Abstract] [Full Text] [Related]

  • 54. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.
    Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, Chen SC, Eschenauer G, Getsinger DL, Gonzalez GM, Govender NP, Grancini A, Hanson KE, Kidd SE, Klinker K, Kubin CJ, Kus JV, Lockhart SR, Meletiadis J, Morris AJ, Pelaez T, Quindós G, Rodriguez-Iglesias M, Sánchez-Reus F, Shoham S, Wengenack NL, Borrell Solé N, Echeverria J, Esperalba J, Gómez-G de la Pedrosa E, García García I, Linares MJ, Marco F, Merino P, Pemán J, Pérez Del Molino L, Roselló Mayans E, Rubio Calvo C, Ruiz Pérez de Pipaon M, Yagüe G, Garcia-Effron G, Guinea J, Perlin DS, Sanguinetti M, Shields R, Turnidge J.
    Antimicrob Agents Chemother; 2015 Nov 01; 59(11):6725-32. PubMed ID: 26282428
    [Abstract] [Full Text] [Related]

  • 55. Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia.
    Berrio I, Maldonado N, De Bedout C, Arango K, Cano LE, Valencia Y, Jiménez-Ortigosa C, Perlin DS, Gómez BL, Robledo C, Robledo J, Grupo GERMEN.
    J Glob Antimicrob Resist; 2018 Jun 01; 13():254-260. PubMed ID: 29183771
    [Abstract] [Full Text] [Related]

  • 56. Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.
    Garcia-Effron G, Park S, Perlin DS.
    Antimicrob Agents Chemother; 2011 May 01; 55(5):2245-55. PubMed ID: 21383097
    [Abstract] [Full Text] [Related]

  • 57. Clinical perspectives on echinocandin resistance among Candida species.
    Shields RK, Nguyen MH, Clancy CJ.
    Curr Opin Infect Dis; 2015 Dec 01; 28(6):514-22. PubMed ID: 26524326
    [Abstract] [Full Text] [Related]

  • 58. Breakthrough invasive candidiasis in patients on micafungin.
    Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD.
    J Clin Microbiol; 2010 Jul 01; 48(7):2373-80. PubMed ID: 20421445
    [Abstract] [Full Text] [Related]

  • 59. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria.
    Pfaller MA, Diekema DJ, Jones RN, Castanheira M.
    J Clin Microbiol; 2014 Sep 01; 52(9):3223-9. PubMed ID: 24951808
    [Abstract] [Full Text] [Related]

  • 60. Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.
    Arendrup MC, Rodriguez-Tudela JL, Park S, Garcia-Effron G, Delmas G, Cuenca-Estrella M, Gomez-Lopez A, Perlin DS.
    Antimicrob Agents Chemother; 2011 Apr 01; 55(4):1580-7. PubMed ID: 21245440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.